Importantly, ​​high expression levels of ITGA3/5/6 correlate with advanced tumor stage, lymph node metastasis, and poor patient survival​​, suggesting their potential as ​​prognostic biomarkers​​ and ​​therapeutic targets​​. Here, ITGA3 is linked to neoplasm.